Erasmus Medical Center, Rotterdam is partnering with Olink to deepen understanding of disease progression and accelerate the development of novel therapies
June 16, 2022 08:00 ET
|
Olink Proteomics AB
UPPSALA, Sweden, June 16, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that the Human Genomics Facility of the Erasmus Medical Center in Rotterdam has adopted the...
FinnGen selects Olink to accelerate leading Population Health Study
June 13, 2022 08:00 ET
|
Olink Proteomics AB
UPPSALA, Sweden , June 13, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that FinnGen in Finland will use Olink technology to provide detailed proteomics data to...
FinnGen selects Olink to accelerate leading Population Health Study
June 13, 2022 08:00 ET
|
Olink Proteomics AB
UPPSALA, Sweden, June 13, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that FinnGen in Finland will use Olink technology to provide detailed proteomics data to...
Ultima Genomics and Olink collaborate to develop solution for high-throughput proteomics
June 08, 2022 08:00 ET
|
Olink Proteomics AB
Proof of concept data show potential to combine the Olink® Explore assay with readout on Ultima Genomics’ sequencing platform for high-throughput proteomics applications Olink continues its...
Ultima Genomics and Olink collaborate to develop solution for high-throughput proteomics
June 08, 2022 08:00 ET
|
Olink Proteomics AB
Proof of concept data show potential to combine the Olink® Explore assay with readout on Ultima Genomics’ sequencing platform for high-throughput proteomics applications Olink continues its...
Element Biosciences and Olink collaborate to enable Olink® Explore on the Element AVITI™ System
June 07, 2022 08:00 ET
|
Olink Proteomics AB
Element Biosciences to provide proof-of-concept findings during panel discussion at the Advances in Genome Biology and Technology (AGBT) general meeting Olink continues its pioneering efforts to...
Singular Genomics and Olink collaborate to enable Olink® Explore on the G4 Max Read™ sequencing kits
June 07, 2022 08:00 ET
|
Olink Proteomics AB
Max Read kits on the G4 Sequencing Platform will produce up to 4 billion reads per run, enabling high throughput, cost-effective proteomics research Olink continues its pioneering efforts to enable...
Singular Genomics and Olink collaborate to enable Olink® Explore on the G4 Max Read™ sequencing kits
June 07, 2022 08:00 ET
|
Olink Proteomics AB
Max Read kits on the G4 Sequencing Platform will produce up to 4 billion reads per run, enabling high throughput, cost-effective proteomics research Olink continues its pioneering efforts to enable...
Element Biosciences and Olink collaborate to enable Olink® Explore on the Element AVITI™ System
June 07, 2022 08:00 ET
|
Olink Proteomics AB
Element Biosciences to provide proof-of-concept findings during panel discussion at the Advances in Genome Biology and Technology (AGBT) general meeting Olink continues its pioneering efforts...
Pharma Foods International and Olink initiate strategic partnership in Japan
June 02, 2022 08:00 ET
|
Olink Proteomics AB
UPPSALA, Sweden, and KYOTO, Japan, June 02, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that Pharma Foods International in Japan has initiated a partnership to use...